Reding Andrew P. 4
4 · Inogen Inc · Filed Jul 9, 2026
Research Summary
AI-generated summary of this filing
Inogen (INGN) EVP Andrew Reding Receives 130,000 RSUs
What Happened
- Andrew P. Reding, Executive Vice President and Chief Operating Officer of Inogen (INGN), was awarded 130,000 restricted stock units (RSUs) on July 6, 2026. The Form 4 shows an acquisition (code A) of 130,000 derivative units at $0.00 per unit — these are contingent rights to receive shares, not an open-market purchase or sale.
Key Details
- Transaction date: 2026-07-06; Form 4 filed: 2026-07-09 (appears to be filed after the typical two-business-day Form 4 deadline).
- Award: 130,000 RSUs, reported with $0.00 per unit (derivative award, code A).
- Footnote F1: Each RSU represents a contingent right to one share of Inogen common stock upon vesting.
- Footnote F2: Vesting schedule — subject to continued service: 1/3 vests one year from the Vesting Commencement Date (Sept 1, 2026) and then 1/3 vests on the same day each year thereafter.
- Shares owned after the transaction: not specified in the provided filing excerpt.
Context
- RSUs are compensation awards that convert to actual shares only upon vesting; they do not represent an immediate market purchase or sale. This grant reflects executive compensation structure rather than an immediate trading signal.
Insider Transaction Report
Form 4
Inogen IncINGN
Reding Andrew P.
EVP, COO
Transactions
- Award
Restricted Stock Unit
[F1][F2]2026-07-06−130,000→ 130,000 total→ Common Stock (130,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
- [F2]Subject to the reporting person's continued service, 1/3rd of the restricted stock units will vest one year from September 1, 2026 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.
Signature
/s/ Mary Wright, as Attorney-in-Fact|2026-07-09